COMPASS PATHWAYS PLC Other Current Assets
COMPASS PATHWAYS PLC (CMPS) had Other Current Assets of $8.13 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Current $8.13M.
- 2026-03-31: Other Assets, Current $7.33M.
- 2025-12-31: Other Assets, Current $5.58M.
- 2025-09-30: Other Assets, Current $2.75M.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $8.13M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $7.33M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.58M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $2.75M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $1.74M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $2.42M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $3.58M 10-K · filed 2026-03-24 | $2.19M 10-K · filed 2025-02-27 |
| 2024-09-30 | $1.78M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $2.70M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.72M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $1.90M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $2.08M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.15M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.49M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.04M 10-K · filed 2024-02-29 | $945.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $1.27M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $951.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.33M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $1.37M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $1.06M 6-K · filed 2021-11-09 | |
| 2021-06-30 | $1.05M 6-K · filed 2021-08-11 | |
| 2020-12-31 | $509.00K 10-K · filed 2022-02-24 | $796.00K 20-F · filed 2021-03-09 |
| 2019-12-31 | $740.00K 20-F · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |